Search Tag: CLABSI

Executive Health Management

2020 23 Apr

HAIs are costly both in terms of harm/mortality and cost. Close attention to aseptic practices and monitoring patients can greatly reduce the incidence of these infections. Central Line-Associated Bloodstream infections (CLABSIs) are the most costly type of hospital-acquired infections, both in terms of morbidity and mortality, and financial...Read more

ICU Management

2019 30 Mar

Central line-associated bloodstream infections (CLABSI) result from contamination of a central line, a catheter (tube) that is inserted in a large vein in the neck, chest, or groin, used to measure pressures, and to give medication or fluids. CLABSI can occur due to breaks in infection control care practices during insertion of the central line or...Read more

ICU Management

2018 06 Mar

Machine learning has proven to be useful for developing prediction models for outcomes in intensive care unit patients. A new study comparing machine learning techniques for predicting central line-associated bloodstream infection (CLABSI) shows supervised artificial intelligence can accurately predict CLABSI in patients admitted to the ICU. Early...Read more

ICU Management

2016 07 Mar

Evaluation of a central catheter maintenance bundle developed to prevent central line-associated bloodstream infections (CLABSIs) found that it led to decreased infection rates, according to a study published in the American Journal of Critical Care (AJCC) . The bundle comprises 14 items and has a 5 point checklist to monitor compliance.  In this...Read more

ICU Management

2015 22 Oct

A new study from Mount Sinai School of Medicine shows that implementation of electronic health records (EHR) at a large tertiary hospital resulted in significant reductions in central line-associated bloodstream infections (CLABSI) and surgical intensive care unit (SICU) mortality rates. The findings are published in CHEST Journal . Health information...Read more

ICU Management

2015 24 Apr

According to a report by the researchers from the Johns Hopkins Armstrong Institute for Patient Safety and Quality, interventions focused on evidence-based infection prevention practices, safety culture and teamwork, and scheduled measurement of infection rates considerably reduced central line-associated bloodstream infections (CLABSIs) across intensive...Read more

ICU Management

2013 09 Jul

CorMedix Inc. announced on July 5, 2013, that it received CE Mark approval for Neutrolin®, a catheter lock solution, for patients with central venous catheters on hemodialysis secondary to advanced chronic kidney disease. The Neutrolin solution includes an anti-coagulant and broad-spectrum antimicrobial (antibacterial and antifungal) combination that...Read more

ICU Management

2013 29 May

Peter J. Pronovost, M.D., Ph.D., senior vice president for patient safety for Johns Hopkins Medicine and one of the authors of the research. Pronovost is also editorial board of member of ICU Management. Private insurers rather than hospitals would reap the most savings by supporting programs to prevent these avoidable complications . Johns...Read more